Fu-ren Zhang
27397 Jingshi Road
Jinan, 250022, China
Jinan, 250022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: June 16, 2024
Cutaneous blisters mimicking bullous pemphigoid.
Journal: The Lancet. Oncology
Published: November 15, 2023
Prevalence and associated factors of sexually transmitted infections among methamphetamine users in Eastern China: a cross-sectional study.
Journal: BMC infectious diseases
Published: July 12, 2021
A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasis.
Journal: Chinese medical journal
Published: November 12, 2020
Consensus on Pre-examination and Triage in Clinic of Dermatology During Outbreak of COVID-19 From Chinese Experts.
Journal: International journal of dermatology and venereology
Published: March 02, 2020
Efficacy and safety of Run Zao Zhi Yang capsule on chronic eczema: a multiple-center, randomized, double-blind, placebo-controlled clinical study.
Journal: The Journal of dermatological treatment
Published: June 21, 2019
Glycyrrhizin combined with acitretin improve clinical symptom of psoriasis via reducing Th17 cell differentiation and related serum cytokine concentrations.
Journal: International journal of clinical and experimental medicine
Published: June 03, 2015
Infliximab monotherapy for Chinese patients with moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled multicenter trial.
Journal: Chinese medical journal
Published: August 14, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026